National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College; Department of Pulmonary and Critical Care Medicine Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China
Professor Zhai is a leading expert in pulmonary vascular medicine and venous thromboembolic diseases. His work focuses on the diagnosis, treatment, and prevention of pulmonary embolism, pulmonary hypertension, and chronic thromboembolic pulmonary hypertension (CTEPH), with a particular interest in molecular mechanisms, vascular remodeling, and clinical and translational research. He has led multiple national research projects supported by the National Natural Science Foundation of China and the National Key Research and Development Program. He has published more than 200 articles in leading journals, including The Lancet, the European Respiratory Journal, and CHEST, and major Chinese medical journals. He has served as a principal contributor to 15 national and international clinical guidelines and expert consensus statements on pulmonary embolism and pulmonary vascular diseases.
He currently serves as Chair of the Expert Panel on Pulmonary Embolism and Pulmonary Vascular Disease Care Capacity Development, Chinese Medical Doctor Association; Standing Vice Chair of the Pulmonary Embolism and Pulmonary Vascular Diseases Group of the Chinese Thoracic Society; Member of the Pulmonary Circulation Assembly of the American Thoracic Society (ATS); China Regional Lead of the International VTE Research Network (INVENT); and President-Elect of the Pulmonary Circulation Assembly of the Asian Pacific Society of Respirology (APSR).
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital), Nanjing, China
Prof. Xie holds multiple leadership roles in national and provincial academic societies, including Executive Member of the Internal Medicine Branch of the Chinese Medical Association, Chair of the Internal Medicine Branch of the Jiangsu Medical Association, and Executive Member of the Respiratory Medicine Branch of the Jiangsu Medical Association. She also serves as Vice Leader of the Pulmonary Embolism and Pulmonary Vascular Disease Group of the Jiangsu Medical Association, President-Elect of the Internal Medicine Physicians Branch of the Jiangsu Medical Doctor Association, and Executive Director of the Jiangsu Antituberculosis Association. Professor Xie is a recipient of several prestigious provincial awards, including multiple Jiangsu Science and Technology Progress Awards and Jiangsu Medical Science Awards.
The First Hospital of Shanxi Medical University, Taiyuan, China
Dr. Shi Yiwei serves as Vice President of the First Hospital of Shanxi Medical University, holding the academic ranks of Chief Physician, Medical Doctor, Master's and Doctoral Supervisor. With extensive expertise in the diagnosis, treatment, and research of pulmonary embolism and pulmonary vascular diseases, pneumoconiosis, and respiratory critical care, he has accumulated substantial clinical and academic experience in respiratory medicine. His leadership roles include Member of the Respiratory Disease Prevention and Control Committee of the Chinese Preventive Medicine Association, Member of the Youth Committee of the Chinese Medical Association Respiratory Disease Branch, and President-elect of the Shanxi Medical Doctor Association Respiratory Physician Branch, etc. In recent years, Dr. Shi has led 8 provincial and ministerial-level research projects, published multiple SCI-indexed papers, and authored 3 first-author papers in Chinese Medical Association journals. He has also participated in 3 invention patents.
Temple University Hospital, Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Philadelphia, PA, United States
Parth M. Rali is an Associate Professor in the Department of Thoracic Medicine and Surgery at Temple University Hospital, Lewis Katz School of Medicine, United States. He is a nationally and internationally recognized clinician-scholar in pulmonary vascular disease, pulmonary embolism, and critical care medicine. Dr. Rali serves as the Director of the Pulmonary Embolism Response Team (PERT) Program at Temple University Hospital System and has played a pivotal role in advancing multidisciplinary, protocol-driven care models for acute and chronic thromboembolic disease. He holds multiple leadership positions in major professional societies, including Chair of the National PERT Consortium Clinical Protocol Committee and Vice Chair roles within the American Thoracic Society and the American College of Chest Physicians pulmonary vascular networks. Actively involved in guideline development, clinical research, and physician education, Dr. Rali has been widely recognized for his academic, educational, and clinical contributions, and is regarded as a leading authority shaping contemporary practice and future directions in pulmonary embolism and pulmonary vascular medicine.
Department of Physiology, Peking Union Medical College, Beijing, China
https://yzbss.pumc.edu.cn/basicinfo/tutorinfo/tutordetail/J2021060009
email: peiran.yang@foxmail.com
Tenure-track Professor, Peking Union Medical College; Principal Investigator, National Key Laboratory; Doctoral Supervisor, Department of Physiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences.
Dr. Yang obtained his PhD in Biomedical Sciences from University of Cambridge and completed postdoctoral training at Harvard Medical School. His research focuses on pulmonary vascular remodeling and respiratory diseases, particularly pulmonary vascular disorders and their comorbidities. He has conducted a series of original studies targeting key signaling pathways and advanced the translational development of a novel drug that has been approved for clinical use. His work has been published in leading journals, including Circulation, Science Translational Medicine, and The New England Journal of Medicine, and he is a recipient of an international award from the British Pharmacological Society. His laboratory employs a multi-level research framework spanning population cohorts to molecular systems, integrating approaches such as multi-omics analyses, organoid models, and translational therapeutic development.